P
Overview
PursueCare provides telehealth addiction recovery and mental health services through a virtual clinic accessed via a mobile app. Its platform offers MAT, therapy and counseling, psychiatry, at-home lab testing, delivered by a multidisciplinary team, plus PursueCareRx, an in-house pharmacy for discreet home delivery. It differentiates itself with in-network partnerships across health systems, hospitals, employers, and plans, and by adding FDA-approved digital therapeutics reSET and reSET-O. The goal is to dismantle barriers to treatment by using technology to offer private, accessible, integrated care for underserved and remote communities.
Work here?Claim your company
Simplify's take
What believers are saying
- XRHealth’s acquisition expands distribution across smartphones, smartwatches, and VR support groups.
- PursueCare’s partner model with emergency departments and health systems drives lower-friction patient acquisition.
- PursueCareRx and FDA-authorized therapeutics strengthen outcomes tracking and reimbursement conversations.
What critics are saying
- XRHealth bought PursueCare on November 9, 2026, ending its independence and brand control.
- Payer and partner concentration remains severe; losing Medicaid or hospital contracts would crush growth.
- Digital therapeutics integration is fragile; if XRHealth deprioritizes RESET, PursueCare loses its moat.
What makes PursueCare unique
- PursueCare combines addiction telehealth, psychiatry, counseling, and pharmacy delivery in one workflow.
- Its FDA-authorized RESET and RESET-O digital therapeutics add app-based CBT and contingency management.
- It serves Medicaid and Medicare patients across six states, including CT, KY, ME, NH, OH, and WV.
Help us improve and share your feedback! Did you find this helpful?